Literature DB >> 17295093

Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?

Vassilios Vassiliou1, Christine Kalogeropoulou, Theodoros Petsas, Michael Leotsinidis, Dimitrios Kardamakis.   

Abstract

PURPOSE: To investigate the association between the clinical status of patients with metastatic bone disease and the type of bone metastases. PATIENTS AND METHODS: 80 patients with skeletal metastases underwent both clinical and radiological assessments. Bone lesions were evaluated with computed tomography (CT), and patients were separated into three groups: lytic, mixed, sclerotic. Bone density of each lesion was measured in Hounsfield units (HU).
RESULTS: Patients with osteolytic lesions had the highest mean pain score with 8.1 +/- 2.2 points, the least mean scores for quality of life (QoL) and performance status (PS) with 31.4 +/- 14.6 and 58.6 +/- 9.7 points respectively, the highest percentage and mean opioid consumption (100% and 220.9 mg of oral daily morphine equivalent respectively), and the least mean bone density (116.3 +/- 40.4 HU). On the contrary, the group with sclerotic metastases had the least mean pain score with 4.6 +/- 1.3 points, the highest mean scores of QoL and PS (61.1 +/- 15.5 and 66.6 +/- 10 points respectively), the least percentage and mean opioid requirement (55.5% and 170.6 mg respectively), and the highest mean bone density (444 +/- 86.6 HU). The differences between the three groups were statistically significant for all parameters evaluated, apart from performance status between the sclerotic and mixed groups. The correlation coefficients were statistically significant between all parameters investigated. Bone density had a strong negative correlation with pain.
CONCLUSION: Our results show a clear correlation between the type of bone metastases and the clinical status of patients. Patients with excessive bone resorption suffer the most, and may be given priority in treatment. CT proved to be a practical and efficient method to investigate and classify metastatic bone lesions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17295093     DOI: 10.1007/s10585-007-9056-z

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   4.510


  14 in total

Review 1.  Bone metastasis in breast cancer: the role of parathyroid hormone related protein.

Authors:  J Iddon; G Byrne; N J Bundred
Journal:  Surg Oncol       Date:  1999-07       Impact factor: 3.279

2.  Clinics in diagnostic imaging (82). Lesser trochanter metastasis.

Authors:  W C G Peh; M Muttarak
Journal:  Singapore Med J       Date:  2003-02       Impact factor: 1.858

Review 3.  Metastatic bone disease: clinical features, pathophysiology and treatment strategies.

Authors:  R E Coleman
Journal:  Cancer Treat Rev       Date:  2001-06       Impact factor: 12.111

Review 4.  Metastatic bone disease: clinical and therapeutic aspects.

Authors:  J J Body
Journal:  Bone       Date:  1992       Impact factor: 4.398

Review 5.  Novel therapeutic approaches to cancer patients with bone metastasis.

Authors:  R Maisano; S Pergolizzi; S Cascinu
Journal:  Crit Rev Oncol Hematol       Date:  2001-12       Impact factor: 6.312

6.  Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease.

Authors:  J J Vinholes; O P Purohit; M E Abbey; R Eastell; R E Coleman
Journal:  Ann Oncol       Date:  1997-12       Impact factor: 32.976

7.  Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment.

Authors:  Vassilios Vassiliou; Christine Kalogeropoulou; Christos Christopoulos; Ekaterini Solomou; Michael Leotsinides; Dimitrios Kardamakis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-11-02       Impact factor: 7.038

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

9.  Detection of simulated osteoporosis in maxillae using radiographic texture analysis.

Authors:  T E Southard; K A Southard
Journal:  IEEE Trans Biomed Eng       Date:  1996-02       Impact factor: 4.538

10.  Computed tomography (CT) evaluation of breast cancer patients with osteolytic bone metastases undergoing palliative radiotherapy--a feasibility study.

Authors:  Edward Chow; Lori Holden; Joel Rubenstein; Monique Christakis; Katharina Sixel; Marjan Vidmar; Joel Finkelstein; Charles Hayter; Andrew Loblaw; Rebecca Wong; Ewa Szumacher; Cyril Danjoux
Journal:  Radiother Oncol       Date:  2004-03       Impact factor: 6.280

View more
  7 in total

1.  Types of bone metastases in women with breast cancer undergoing systemic treatments.

Authors:  V Vassiliou; D Kardamakis; C Cosimo Quattrocchi; P Dell'aia; B Beomonte Zobel
Journal:  Radiol Med       Date:  2008-08       Impact factor: 3.469

2.  Factors related to the quality of life in patients with bone metastases.

Authors:  Yusuke Shinoda; Ryoko Sawada; Futaba Yoshikawa; Takahiro Oki; Toshihide Hirai; Hiroshi Kobayashi; Ko Matsudaira; Hiroyuki Oka; Sakae Tanaka; Hirotaka Kawano; Nobuhiko Haga
Journal:  Clin Exp Metastasis       Date:  2019-07-18       Impact factor: 5.150

3.  Rectal carcinoma revealed by isolated mixed bone metastases.

Authors:  Maroua Slouma; Maissa Abbes; Rim Dhahri; Nour Elhouda Gueddiche; Issam Msekni; Imen Gharsallah; Leila Metoui; Bassem Louzir
Journal:  Clin Case Rep       Date:  2022-02-01

Review 4.  Biomechanical Properties of Metastatically Involved Osteolytic Bone.

Authors:  Cari M Whyne; Dallis Ferguson; Allison Clement; Mohammedayaz Rangrez; Michael Hardisty
Journal:  Curr Osteoporos Rep       Date:  2020-10-19       Impact factor: 5.096

5.  Bone Density Changes Following Radiotherapy to Vertebral Metastases.

Authors:  Garrett L Jensen; Ravi Gaddipati; Kendall P Hammonds; Andrew Morrow; Gregory P Swanson
Journal:  Cureus       Date:  2021-06-03

6.  A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate.

Authors:  Vassilios Vassiliou; Christine Kalogeropoulou; Efstathia Giannopoulou; Michael Leotsinidis; Irine Tsota; Dimitrios Kardamakis
Journal:  Clin Exp Metastasis       Date:  2007-04-18       Impact factor: 4.510

7.  The Role of the Size and Location of the Tumors and of the Vertebral Anatomy in Determining the Structural Stability of the Metastatically Involved Spine: a Finite Element Study.

Authors:  Fabio Galbusera; Zhihui Qian; Gloria Casaroli; Tito Bassani; Francesco Costa; Benedikt Schlager; Hans-Joachim Wilke
Journal:  Transl Oncol       Date:  2018-03-28       Impact factor: 4.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.